Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden · Delayed Price · Currency is SEK 0.1265
-0.0060 (-4.53%)
Feb 11, 2026, 9:36 AM CET
Spago Nanomedical AB Market Cap
Spago Nanomedical AB has a market cap or net worth of 87.66 million as of February 11, 2026. Its market cap has increased by 19.88% in one year.
Market Cap
87.66M
Enterprise Value
57.99M
Revenue
4.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
Market Cap Chart
Since January 16, 2013, Spago Nanomedical AB's market cap has increased from 46.44M to 87.66M, an increase of 88.75%. That is a compound annual growth rate of 4.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 87.66M | 13.73% |
| Dec 30, 2025 | 77.07M | 12.93% |
| Dec 30, 2024 | 68.25M | -4.38% |
| Dec 29, 2023 | 71.37M | 24.57% |
| Dec 30, 2022 | 57.29M | -71.02% |
| Dec 30, 2021 | 197.67M | -26.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 129.61M |
| Simris Group AB (PUBL) | 126.32M |
| Annexin Pharmaceuticals AB | 112.24M |
| Biosergen AB | 106.61M |
| Active Biotech AB | 101.22M |
| Alligator Bioscience AB | 96.21M |
| Scandinavian ChemoTech AB | 82.87M |
| Alzinova AB | 73.97M |